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ABSTRACT 
Objectives: To determine the relative prevalence of human infec- 
tions attributable to Streptobacillus moniliformis in California 
over the past 3 decades. 
Methods: A retrospective analysis of all the data collected was 
conducted on S. moniliformis cultures identified by the Micro- 
bial Diseases Laboratory (MDL) from January 1970 to Decem- 
ber 1998. 
Results: Information on a total of 45 S. moniliformis isolates 
was analyzed. Overall, 91% of the isolates were from human 
sources; 58% were received since 1990. These strains were 
divided almost equally between males and females, with 50% 
of the isolates from patients 9 years old or younger. In 75% of 
the cases of human infections where a diagnosis was given, 
rat-bite fever (RBF) was suspected; 83% of these suspected 
cases involved either a known rat bite or exposure to rodents. 
Conclusions: As crowding becomes an increasing environ- 
mental reality, humans are more frequently being exposed to 
zoonotic diseases as a result of encounters with “wild” ani- 
mals. Domesticated animals also are exposed more frequently 
to wild animals; thus, increasing human exposure to once rare 
zoonotic illnesses. Rat-bite fever is a disease that seems to be 
easily recognizable by clinicians, easily identified in the clinical 
laboratory (if suspected), and successfully treated when the 
appropriate therapy is administered. Physicians should con- 
sider RBF as a possible diagnosis when fever, rash, and expo- 
sure to rats are part of the patient’s history. 
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A seldom encountered zoonotic pathogen seen by clini- 
cal laboratories is Streptobacillus moniliformis. This pleo- 
morphic, facultatively anaerobic, gram-negative bacterium 
is traditionally associated with direct or indirect expo- 
sure to rats, the natural reservoir for S. moniliformis. Its 
distribution is worldwide. I-3 
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Two distinct clinical syndromes have been identified 
in association with S. moniliformis infection. One, Haver- 
hill fever, originally recognized in 1926, is an infection 
transmitted to humans through the consumption of con- 
taminated water, milk, or food previously in contact with 
rats.‘,* The disease is characterized by a high incidence 
of pharyngitis and pronounced vomiting. 
The more common syndrome associated with S. 
moniliformis infection, however, is rat-bite fever @RF). 
This illness is characterized by abrupt onset of high fevers, 
headaches, severe migratory arthralgia, vomiting, and a 
rash (2-4 days later). The petechial rash develops over 
the extremities, in particular the palms and the soles.’ The 
onset of symptoms typically occurs 10 or more days after 
exposure. Any related wound has usually healed by the 
time symptoms develop. 1-4 Estimates of the mortality rate 
associated with untreated cases of streptobacilliosis 
approach 13/o. o *z5x6 Fatality is most often associated with 
cases in infants and patients with endocarditis.‘,5 
To date, most of the information regarding S. monil- 
zjiwmis infection, and in particular RBF, stems from indi- 
vidual case reports. In light of the increasing incidence 
of human contact with animals, including the care and 
handling of unusual or exotic pets,’ a retrospective 
review of the incidence of streptobacilliosis in California 
over the past 3 decades was conducted and serves as the 
basis of this report. 
MATERIALS AND METHODS 
The Microbial Diseases Laboratory (MDL) is the refer- 
ence laboratory for the state of California. The laboratory 
is responsible for the isolation and identification of bac- 
terial, fungal, and parasitic pathogens of public health sig- 
nificance throughout the state. A system of 39 county 
public health laboratories serves as the conduit for the 
submission of unusual, unidentified, or reportable isolates 
from clinical laboratories to the MDL. 
The MDL identifies or confirms S monilz@m& isolates 
using four tests: (1) a growth requirement of 10 to 20% 
serum; (2) the presence of typical gram-negative bacilli 
(sometimes in chains) and filaments with bulbous swellings 
in a Gram stain (Figure 1); (3) growth in broth (thiogly- 
collate medium) with “puff ball”-colony formation (Figure 
2); and (4) a positive direct fluorescent antibody test using 
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Figure 1. Typical bacilli (some in chains) and filaments with bulbous 
swellings (oil immersion; original magnification X1000). 
an in-house produced polyclonal antibody. The polyclonal 
antibody was prepared from whole cell antigens of S. 
monilzjbrmis strain MDL 56-3. Formalized whole cell anti- 
gen was washed and used to immunize rabbits. Rabbits 
were immunized five times over a 2-week period by intm- 
venous injection through the marginal vein. Serum was 
collected and fluorescein isothiocyanate @ITC) conjugated. 
Quality control was performed on the conjugate by test- 
ing it against various S. monz’ZziformB strains at several work- 
ing dilutions. Original laboratory reports were reviewed 
and data from these were compiled to produce the results. 
RESULTS 
Since 1970, the MDL has received 45 isolates of S. monil- 
iform&. Forty-one (91%) isolates were from human 
sources; of these, 24 (58%) have been received since 
1990 (Figure 3). These 41 isolates were received from 19 
different local (county) jurisdictions, with a majority of 
strains (61%) received from four county and one city 
public health laboratories: Sacramento (n = 8) Los Ange- 
les (n = 6) Santa Clara (n = 5) San Diego and San Fran- 
cisco (n = 3 each). Most infections were centered around 
densely populated areas and no infections were reported 
from northern California counties. Geographically, the 
Figure 2. Thioglycollate broth with “puff ball” colonies. 
41 S. monilzjbrmis infections were from southern Cali- 
fornia (n = 14) the San Francisco Bay area (n = 11) the 
San Joaquin valley (n = 9), North San Francisco Bay area 
(n = 3) Monterey Bay area (n = 3) and Sierra Foothills 
(n = 1). The male to female ratio was 1.0:1.2 with 19 
(46%) male and 22 (54%) female patients. The age ranged 
from 6 weeks to 92 years (mean, 46 y) (Figure 4). The 
average age was just under 19 years. 
The most common isolate source of S. moniliformis 
in human infections was blood (78%) followed by aspi- 
rates (12%) and wounds (10%). Common media used to 
isolate S. moniliformis from blood included pediatric 
BACTECTM Plus blood culture bottles (BD Diagnostics, 
Sparks, MD) (n = 5) trypticase soy blood culture bottles, 
with or without supplementation (n = 4) anaerobic blood 
culture bottles (type not specified, n = 3) and thiogly- 
collate broth (n = 1). For nonblood isolates (e.g., wounds) 
blood agar was the most common media used to recover 
S. moniliformis. Some of the histories included the num- 
ber of times S. moniliformis was isolated from the blood 
per patient (n = 28); the results were as follows: 17 (61%) 
were isolated once, eight (29%) were isolated twice, and 
three (10%) were isolated three or more times. From the 
other sources with this information (n = 5) four (80%) 
were isolated only once per patient, and the remaining 
wound isolate was positive by culture more than three 
times. The range of onset times (n = 9) was 2 to 7 days, 
with four (44%) patients exhibiting symptoms within 3 
Rat-Bite Fever / Graves and Janda 153 
Figure 3. Prevalence of S. moniliformis infections by year in Califor- 
nia, 1970-98. 
days of exposure. Table 1 lists selected characteristics of 
the patients in this study. 
When patients presented with at least two of the three 
classic symptoms (fever, rash, arthritis) and a history of rat 
exposure, clinicians suspected RBF in 44% of the cases. 
Another 19% were diagnosed with RBF if there was an 
exposure to rats but only one of the three classic symp 
toms. One astute practitioner diagnosed RBF in a patient 
with no history of exposure to rats or any of the three 
major symptoms. In patients presenting with at least two 
of the major symptoms and having a history of a different 
animal exposure (to a mouse and a squirrel, respectively), 
two clinicians suspected RBF Several authors have reported 
RBF following exposures to animals other than rats.‘,x 
Symptom combinations varied greatly in the cases 
included in this study. The greatest percentage of the 
patients exhibited fever with rash (28%), followed by 
patients having all three classic symptoms: fever, rash, and 
arthritis (22%). Several histories showed fever with arthri- 
tis (17%). Only one patient had a rash with arthritis and 
no fever. Four of the cases (11%) had fever without rash 
or arthritis. 
Figure 4. Prevalence of S. moniliformis infections by age in Califor- 
nia, 1970-98. 
Table 1. Selected Characteristics of Patients with S. 
moni/i~omis Infections 
Characteristic* 
Percentage of 
Patients*+ 
Presenting diagnosis (n = 32) 
Rat-bite fever 
RBFILeptospirosis or Kawasaki or septic arthritis 
Streptobacillus bacteremia/rheumatic fever 
Arthritis (reactive or rheumatoid) 
Fever 
Sepsis 
Tendinitis 
Wound infection 
Presenting symptoms (n = 34) 
Fever 
Arthritis/arthralgia 
Rash 
Fatigue/malaise 
Headache 
Chills 
Animal exposure (n = 35) 
Pet rat 
School rat 
Other rat exposure 
Wild rat 
Mouse 
Squirrel 
Exposure not known 
Rat exposure (n = 31) 
Bite 
Other rat association 
Scratch 
Kiss 
Therapy (n = 25) 
Penicillin alone 
Penicillin along with other antibiotics 
Ampicillin or amoxicillin or clavulanic acid 
Other antibiotics 
63 
9 
3 
9 
6 
3 
3 
3 
88 
73 
65 
20 
18 
15 
54 
14 
11 
9 
3 
3 
6 
61 
26 
10 
3 
44 
12 
12 
32 
*Based on 41 cases: r? In column one denotes the number of cases in which 
data were available. 
+Age range, 6 weeks to 92 years (mean, 46 y); male to female ratio of 41 
patients was 1 .0:1.2. 
In the present study, exposure to pet rats accounted 
for the greatest risk. All the pet rat exposures except one 
took place in the owner’s or a friend’s home. The excep- 
tion occurred in a pet store. This source of exposure is 
not commonly acknowledged in the current literature as 
the greatest risk. Three of the school rat exposures were 
to adults in school and could more accurately be classi- 
fied laboratory exposures. All four other rat exposures 
were rat bites with the “source” of the rat not recorded 
in the exposure history. 
Data confirm that transmission of S. monilzjiwmis to 
humans by rats takes place not only after a bite.‘-‘x5 Thirty- 
nine percent of the cases received the pathogen as the 
result of exposure other than a bite that included 
scratches, kissing, or unknown mode of transmission. 
In two of the patients treated with ampicillin-amox- 
icillin or ampicillin and clavulanic acid, gentamicin was 
also part of the regime. The “other antibiotics” category 
in Table 1 includes six patients treated with a variety of 
antibiotics, including erythromycin-tetracycline-clin- 
damycin, cefotaxime, cephalosporins, cephalothin- 
cephalexin, doxycycline, and gentamicin. 
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DISCUSSION 
The MDL has confirmed 41 cases of S. moniliformis asso- 
ciated with RBF between 1970 and 1998. Because this 
disease is not reportable, 8,9 the incidence is difficult to 
measure. Overall numbers (1.5 cases/y), however, coincide 
with one report citing an incidence of one to two cases 
per year.6 Twenty-four isolates were received since 1990 
(3.0 cases/y), suggesting a twofold increase and a possi- 
ble rise in the incidence of RBE Potential reasons for this 
increase include more pet and other animal exposure, 
better isolation and identification procedures, a higher 
level of suspicion on the part of clinicians, or some com- 
bination of these three. 
Most RBF infections in California occur in younger 
people (under 12 y) and are associated with septic, febrile 
episodes. In addition, a large percentage of patients (67%) 
presented with signs of arthritis. Although S. monilzjixmis 
was more often isolated from blood than any other site, 
in four cases S. moniltjiwnais was recovered from wounds 
or lesions. This is somewhat unusual in that classic 
descriptions suggest that wounds usually have healed by 
the time symptoms appear and the RBF diagnosis is enter- 
tained.‘-* Depending on whether or not a rash or poly- 
arthritis accompany febrile episodes of RBF, the 
differential diagnosis can also include brucellosis, lep- 
tospirosis, Rocky Mountain spotted fever, Lyme disease, 
viral exanthems, disseminated sexually-transmitted dis- 
eases, and a variety of other infective or vascular 
processes. I,3 Whenever a history of exposure to rats is 
revealed, RBF is highly suggested. 
Several findings from this retrospective study are 
noteworthy. Two cases of RBF were associated with expo- 
sure to animals other than rats (squirrel, mice). This illus- 
trates that the diagnosis of RBF cannot be ruled out solely 
on the basis of lack of exposure to rats. Another inter- 
esting finding is that in 29% of the cases, transmission of 
S. monilifornais via rat bites or scratches could not be 
documented. For one young girl, the apparent route of 
transmission involved repeatedly kissing her pet rat. Strep- 
tobacillus monilifornais also can be excreted in the urine 
of rats.lo~l’ Reports have also linked the handling of rats 
(dead or alive) to S. moniliformis infections even with- 
out a noticeable break in the skin.“2 
CONCLUSION 
Increasing exposure to unusual, exotic, or wild animals 
leading to a rise in the frequency of zoonotic diseases is 
becoming a more common occurrence. This factor com- 
bined with the gradual urbanization of previously rural 
areas compounds the risk of exposure. The increasing 
contact between domestic animals, exotic pets, and 
wildlife increases the likelihood that transmission of 
zoonotic diseases among these groups of animals will 
occur, precipitating a rise in zoonotic disease in humans. 
Although it cannot be unequivocally established that 
the increase in S. monilifomnis infections observed in Cal- 
ifornia over the past 8 years is attributable to these fac- 
tors, the twofold increase suggests that this may be the 
case. Regardless of the reason for the increase, prevention 
of serious disease is dependent upon early clinical recog- 
nition, alerting the laboratory of the potential diagnosis, 
use of appropriate laboratory procedures, methods and 
media to recover and identify S. monilifrmis from blood 
or other body fluids and tissues,‘* and institution of appro 
priate antimicrobial therapy (penicillin, tetracycline).‘~3~* 
Measures to decrease the number of RBF cases can 
be instituted. Extermination of rats in urban areas, where 
unintended exposure is highest, can be undertaken. Peo- 
ple can be educated to avoid potentially contaminated 
food (including unpasteurized milk) and water. Finally, 
most laboratory infections can be avoided if laboratory 
workers are gloved and cautious when handling labora- 
tory rodents (alive or dead). 
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